Skip Navigation


ToxSci Advance Access originally published online on April 15, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
73/2/301    most recent
kfg078v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ou, Y. C.
Right arrow Articles by Yang, R. S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ou, Y. C.
Right arrow Articles by Yang, R. S. H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 73, 301-314 (2003)
Copyright © 2003 by the Society of Toxicology


CARCINOGENICITY

Stochastic Simulation of Hepatic Preneoplastic Foci Development for Four Chlorobenzene Congeners in a Medium-Term Bioassay

Ying C. Ou*, Rory B. Conolly{dagger}, Russell S. Thomas{ddagger}, Daniel L. Gustafson§, Michael E. Long§, Ivan D. Dobrev, Laura S. Chubb, Yihua Xu||, Smadar A. Lapidot, Melvin E. Andersen{dagger} and Raymond S. H. Yang,1

* Preclinical Development, Human Genome Sciences, Inc., Rockville, Maryland 20850; {dagger} CIIT Centers for Health Research, Research Triangle Park, North Carolina 27709; {ddagger} Kalypsos, Inc., La Jolla, California 92037; § School of Pharmacy, University of Colorado Health Science Center, Denver, Colorado 80262; Quantitative and Computational Toxicology Group, Center for Environmental Toxicology and Technology, Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, Colorado 80523; and || Department of Oncology, McArdle Laboratory for Cancer Research, Madison, Wisconsin 53706

A combination of experimental and simulation approaches was used to analyze clonal growth of glutathione-S-transferase {pi} (GST-P) enzyme-altered foci during liver carcinogenesis in an initiation-promotion regimen for 1,4-dichlorobenzene (DCB), 1,2,4,5-tetrachlorobenzene (TECB), pentachlorobenzene (PECB), and hexachlorobenzene (HCB). Male Fisher 344 rats, eight weeks of age, were initiated with a single dose (200 mg/kg, ip) of diethylnitrosamine (DEN). Two weeks later, daily dosing of 0.1 mol/kg chlorobenzene was maintained for six weeks. Partial hepatectomy was performed three weeks after initiation. Liver weight, normal hepatocyte division rates, and the number and volume of GST-P positive foci were obtained at 23, 26, 28, 47, and 56 days after initiation. A clonal growth stochastic model separating the initiated cell population into two distinct subtypes (referred to as A and B cells) was successfully used to describe the foci development data for the four chlorobenzenes. The B cells are initiated cells that display a selective growth advantage under conditions that inhibit the growth of initiated A cells or normal hepatocytes. The simulation exercise for the four chlorobenzenes indicates a positive correlation between the estimated net growth rate of B cells during the 2-week regeneration period following partial hepatectomy and final foci volume at the end of the bioassay. This observation is consistent with the sensitivity analysis of model parameters. While TECB, PECB, and HCB all significantly increased foci volume, only HCB increased normal hepatocyte proliferation. Together, these results indicate that examining effects of chemicals on regenerative responses following partial hepatectomy may be a means for understanding the carcinogenicity potential of chlorobenzene compounds.

Key Words: preneoplastic foci; simulation; liver carcinogenesis; clonal growth model; chlorobenzene.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
M. Lohitnavy, Y. Lu, O. Lohitnavy, L. S. Chubb, S. Hirono, and R. S. H. Yang
A Possible Role of Multidrug Resistance-Associated Protein 2 (Mrp2) in Hepatic Excretion of PCB126, an Environmental Contaminant: PBPK/PD Modeling
Toxicol. Sci., July 1, 2008; 104(1): 27 - 39.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
Y. Lu, M. Lohitnavy, M. B. Reddy, O. Lohitnavy, A. Ashley, and R. S. H. Yang
An Updated Physiologically Based Pharmacokinetic Model for Hexachlorobenzene: Incorporation of Pathophysiological States following Partial Hepatectomy and Hexachlorobenzene Treatment
Toxicol. Sci., May 1, 2006; 91(1): 29 - 41.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. S. Randi, C. Cocca, V. Carbone, M. Nunez, M. Croci, A. Gutierrez, R. Bergoc, and D. L. Kleiman de Pisarev
Hexachlorobenzene Is a Tumor Co-carcinogen and Induces Alterations in Insulin-Growth Factors Signaling Pathway in the Rat Mammary Gland
Toxicol. Sci., January 1, 2006; 89(1): 83 - 92.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.